The vulvar immunohistochemical panel (VIP) project: molecular profiles of vulvar Paget's disease.

CONCLUSIONS: This study reveals the expression of PDL-1 and ER and confirms the expression of HER2/AR in VPD; new bases are provided to design multicenter clinical trials on personalized target therapies.
PMID: 31297606 [PubMed - indexed for MEDLINE]

Source: Clinical Genitourinary Cancer - August 30, 2019 Category: Cancer & Oncology Authors: Garganese G, Inzani F, Mantovani G, Santoro A, Valente M, Babini G, Petruzzellis G, Fragomeni SM, Gentileschi S, Bove S, Franchi M, Angelico G, Fagotti A, Scambia G, Zannoni GF Tags: J Cancer Res Clin Oncol Source Type: research